prescription medicine Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients. Heart failure affects ...

A new case-control study published in JAMA Cardiology demonstrates that molecular imaging using gallium-68–labeled fibroblast ...

Most US veterans who have new heart failure with reduced ejection fraction do not receive all four classes of ...

Please provide your email address to receive an email when new articles are posted on . Eplerenone was beneficial to patients regardless of how long they have had heart failure with reduced ejection ...

Please provide your email address to receive an email when new articles are posted on . Quadruple therapy feasible in nearly half of patients with HFrEF at discharge after a decompensated event.

CLEVELAND -- Whether vagal nerve stimulation improved outcomes for heart failure patients with reduced ejection fraction (HFrEF) remained unclear after ANTHEM-HFrEF was terminated early, with the ...

When the sympathetic nervous system is unregulated, it can lead to high blood pressure and elevated heart rate. The combination of sacubitril-valsartan, sold as Entresto, that is currently the only ...

Swedish investigators looked at potassium levels and all-cause mortality in HFrEF patients at 30 days, 12 months, and 5 years. Over all 3 time frames, the sweet spot in terms of lowest hazard risk for ...

Heart failure affects more than 64 million people worldwide (1%–3% in the general adult population) and its prevalence is ...

Among patients with advanced HFrEF, women, compared with men, are less likely to receive an implantable cardiac defibrillator. Women who have advanced heart failure with reduced ejection fraction ...

prescription medicine Despite substantial advances in therapeutic options for HFrEF, significant gaps remain in the use of guideline-directed medical therapy in these patients. Heart failure affects ...